Used by ~50% of acute care hospitals throughout the U.S. RALS connectivity systems provide interfacing to all major glucose meters as well as wide range of non-glucose devices.
Used by ~50% of acute care hospitals throughout the U.S. RALS connectivity systems provide interfacing to all major glucose meters as well as wide range of non-glucose devices.
Personalized dashboards In the New RALS User Interface (available in Version 6.0 SP7), users can personalize the dashboard they see when they first log in to RALS. Instead of a basic status screen, you can choose what snapshots you want to see, like expiring operator certifications, services, and more… and each snapshot can be viewed as a graph, table or text.
New RALS User Interface Key Features and System Offerings - See on-demand videos
*Device Communication: Bi-directional Connectivity — In this two-way, device-dependent communication, RALS systems can upload data as well as receive data from the device. Uni-directional Connectivity — In this one-way, device-dependent, communication, RALS systems can only receive data from the device.
RALS System Benefits for Hospital Connectivity at the Point-of-Care
© 2024 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our
Website Terms and Conditions, Privacy Policy, and Consumer Health Data Privacy Policy. Interest-Based Ads.